Clinical Trials
CDSCO Moves to Online Submission for CGTP Trial Applications
As part of its continued efforts to streamline operations through digitisation, the Central Drugs Standard Control Organisation (CDSCO) has transitioned from offline to online acceptance of clinical trial applications for cell and gene therapies products (CGTP).
The agency has also...
News
Singapore Seeking Pharmaceutical Tariff Concessions from US
The deputy prime minister and trade minister of Singapore, Gan Kim Yong, has announced his plans to visit Washington this July in order to negotiate certain pharmaceutical tariff concessions on exports, thereby looking forward to shielding one of the most...
News
Merck to Acquire Verona for $10B, COPD Drug in Focus
Merck has pulled off another acquisition that happens to fit in its sweet spot, says Rob Davis, its CEO. As Merck acquires Verona Pharma after paying $10 and with it gets its potential blockbuster drug Ohtuvayre, a first-in-class treatment...
News
PDUFA Crucial for Biopharmaceutical Innovation in the US
The United States happens to lead the world when it comes to the discovery and development of innovative medicines. All thanks largely to a regulatory system that enables timely and science-based reviews of novel drugs. A crucial pillar of...
News
The Evolution of Self-Care: Where Vitauthority Fits in the Wellness Era
Over the past few decades, the concept of self-care has evolved dramatically. Gone are the days when occasional spa days or simple checklists of personal hygiene were considered self-care. Nowadays, people are more proactive and make intentional efforts to...
News
Piramal Pharma Expands Lexington Sterile Injectables Plant
Piramal Pharma has started work on the expansion of its Lexington, Kentucky factory. Piramal Pharma held a groundbreaking ceremony at the plant on June 25, 2025, to mark this key milestone and the company's future expansion.
This investment comes at...
Drug Research
China Unveils Innovative Drugs Policy to Boost Development
The National Health Commission and China's National Healthcare Security Administration (NHSA) together unveiled a comprehensive new policy on June 30 called "Several Measures to Support the High-Quality Development of Innovative Drugs". The policy, which was formally unveiled to the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
